Although locoregional OPSCC relapse was independent of p16INK4aexpression, multivariate survival analysis indicated that p16INK4a expression was an independent prognostic indicator for OPSCC, but not HNSCC, after adjustment for clinical T classification, clinical N classification, and treatment modality (18). Here, CDKN2A is linked to head and neck squamous cell carcinoma.